Background: Although the incidence of maternal mortality during Caesarean delivery remains very low, the rate of severe maternal morbidity is increasing. Improvements in obstetric anaesthetic practice have resulted in a dramatic reduction in the risk of maternal death from general anaesthesia. Less clear is whether the risk of severe maternal morbidity differs according to mode of anaesthesia for women undergoing Caesarean delivery. We analysed the association between the mode of anaesthesia and severe maternal morbidity during Caesarean delivery using a nationally representative inpatient database. Methods: We identified 89 225 women undergoing scheduled Caesarean delivery from the Diagnosis Procedure Combination database in Japan, 2010e2013. We defined severe maternal morbidity as the presence of any life-threatening complications and identified women with severe maternal morbidity from the database. Propensity score-matched analysis was carried out to compare the odds of severe maternal morbidity between women who underwent general vs neuraxial anaesthesia. Results: Of 89 225 women, 10 058 received general anaesthesia and 79 167 received neuraxial anaesthesia. In the propensity score-matched analysis with 10 046 pairs, a higher incidence of severe maternal morbidity was observed among patients receiving general (2.00%) rather than neuraxial anaesthesia (0.76%). The odds ratio of severe maternal morbidity was 2.68 (95% CI, 1.97e3.64) among women receiving general compared with neuraxial anaesthesia.
Conclusions: For scheduled Caesarean delivery, general anaesthesia compared with neuraxial anaesthesia is associated with greater odds for severe maternal morbidity. However, we should be cautious with interpretation of these findings because they may be explained by confounding indications.
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Editor's key points
Maternal mortality is now low in developed countries, but there is limited data on morbidity. Using a healthcare database, the impact of mode of anaesthesia on maternal morbidity was explored. Propensity score matched analysis found increased maternal morbidity in patients undergoing general anaesthesia. Further research is needed in this area to confirm this, accounting for potential confounders.
In the 1970s and 1980s, anaesthesia was one of the major risk factors for maternal deaths during Caesarean delivery. 1, 2 In the 1990s, pregnant women who underwent Caesarean delivery with general anaesthesia had a higher risk of maternal mortality than did those with neuraxial anaesthesia; major causes of deaths from general anaesthesia were maternal hypoxia secondary to failed intubation, hypoventilation, aspiration, or other severe respiratory morbidity. 3 Developments and improvements in anaesthetic monitoring and airway devices, as well as updated guidelines for difficult airway management, have reduced the risk of the airway problems during general anaesthesia in pregnant women. 4, 5 As a result, the risk ratio of maternal mortality between general and neuraxial anaesthesia after Caesarean delivery decreased from 16.7 [95% confidence interval (CI), 12.9e21.8] (from 1985 to 1990) to 1.7 (95% CI, 0.6e4.6) (from 1997 to 2002) in the United States. 3, 6 Recently, severe maternal morbidity has gained interest as an important quality indicator of obstetric care because maternal mortality remains extremely low in developed counties, and even in the largest datasets, studies focusing on maternal mortality do not provide sufficient case numbers for analysis. 7 Although not yet universally defined, the indicators of severe maternal morbidity commonly include postpartum haemorrhage, disseminated intravascular coagulation, shock, sepsis, cardiac dysfunction, respiratory dysfunction, pulmonary embolism, cerebrovascular disorders, and neurological problems. 8, 9 Based on data from a population-wide study in the United States, rates of severe maternal morbidity have increased in recent years. 10 For example, the rate of severe maternal morbidity has increased from 0.74% to 1.29% between years 1998e1999 and 2008e2009 in the United States. Among women requiring delivery hospitalization, the main driver for the increase in the rate of severe maternal morbidity is blood transfusion, a key indicator for severe postpartum haemorrhage. 10, 11 Less clear is whether, among those undergoing Caesarean delivery, mode of anaesthesia influences the risks of major haemorrhage and severe maternal morbidity.
The suppressive effect of anaesthetic agents on uterine muscle contraction in pregnant humans and activation of platelet receptor related to platelet aggregation was demonstrated in vitro, which might increase the risk of major haemorrhage among women undergoing Caesarean delivery under general anaesthesia. 12, 13 A prior study for total hip arthroplasty demonstrated that general anaesthesia was associated with a higher incidence of deep surgical site infection, cardiovascular complications, and respiratory complications compared to neuraxial anaesthesia, although simple comparison would be impossible because of differences of characteristics of patients and procedures. 14 The practice guideline for obstetric anaesthesia by the American Society of Anesthesiologists empirically recommends neuraxial anaesthesia in preference to general anaesthesia for most Caesarean deliveries to minimize the risk of anaesthesia-related adverse events. 15 However, whether anaesthetic techniques can influence the incidence of severe maternal morbidity remains unclear.
In the present study, we hypothesized that the mode of anaesthesia is related to severe maternal morbidity during admission for Caesarean delivery. We analysed the association between the mode of anaesthesia and severe maternal morbidity during Caesarean delivery using a Japanese inpatient database with the aim of expanding knowledge of clinical factors contributing towards severe maternal morbidity.
Methods

Data sources and approval
The institutional review board and ethics committee of The University of Tokyo approved this study. The data in the Diagnosis Procedure Combination database were thoroughly de-identified. Given the anonymous nature of the data, the requirement for informed consent was waived.
The Diagnosis Procedure Combination database is a Japanese case-mix system similar to the diagnosis-related groups in Medicare in the United States. This patient classification system was originally launched in 2002 by the Ministry of Health, Labour and Welfare of Japan and is linked to a Japanese lump-sum payment system. The key objectives of the Diagnosis Procedure Combination system are to implement a standardized electronic claims system and to provide transparency of hospital performance. 16e18 In 2012, the database included data on approximately 7 million inpatients from 1057 participating hospitals, representing approximately 50% of acute-care hospitalisations throughout Japan. 19 The database included the following data: hospital identifier, hospital location, and hospital type (academic or non-academic); patient age, height, and weight; diagnosis and comorbidities on admission; and complications that occurred after admission recorded as text data in the Japanese language and by International Classification of Diseases, 10th Revision (ICD-10)
codes. Complications that occurred after admission were clearly differentiated from comorbidities on admission. The database also included the dates of hospital admission and discharge, discharge status, dates and dosages of all drugs and blood products administered, surgery, anaesthesia, and procedures performed. All interventional and surgical procedures were coded in the database with Japanese original codes, namely Japanese medical procedure codes.
Data extraction
In Caesarean delivery, we extracted data on women with the Japanese medical procedure code K8982 (scheduled Caesarean delivery). The definition of scheduled Caesarean delivery in Japan is one that is planned at least 1 day in advance. Women undergoing Caesarean delivery have various antepartum clinical conditions, and these conditions possibly affect the choice of anaesthesia. By focusing on scheduled Caesarean delivery in this study, we aimed to exclude women undergoing intrapartum Caesarean delivery after a trial of labour or women with acute antepartum conditions requiring urgent delivery (e.g. placental abruption or fetal distress) to reduce the influence of potential confounders. We further excluded women with missing data (mode of anaesthesia, BMI, and gestational age at delivery) and those who received both general and neuraxial anaesthesia.
Outcomes
Our primary outcome was the incidence of severe maternal morbidity during admission for scheduled Caesarean delivery. The incidence of each life-threatening complication was set to our secondary outcome. There are three major approaches to the identification of severe maternal morbidity: disease-specific criteria (e.g. severe postpartum haemorrhage, pulmonary embolism), management-based criteria (e.g. need for blood transfusion, emergency hysterectomy), and organ system dysfunctionebased criteria. 21, 22 Combinations of these three groups of criteria are also common. The use of disease-specific criteria is suitable for retrospective studies, although it is less specific. In contrast, organ system dysfunctionebased criteria have more accuracy, although a great deal of effort is needed for data collection. Management-based criteria have intermediate characteristics. 21, 22 In the present study, we adopted combined criteria (disease-specific and management-based) to identify severe maternal morbidity. Severe maternal morbidity was defined as the occurrence of at least one life-threatening complication. We defined life-threatening complications as follows: red blood cell transfusion on the day of delivery, fresh frozen plasma transfusion on the day of delivery, shock requiring administration of vasopressors (the presence of shock was identified from ICD-10 codes, and the use of vasopressors was identified from the records of noradrenaline, dopamine, and dobutamine administration), sepsis, cardiovascular complications (acute myocardial infarction, acute heart failure, acute pericarditis, acute myocarditis, acute cardiomyopathy, aortic dissection, or cardiac complications of anaesthesia), respiratory complications (pneumonia, aspiration pneumonia/airway problems, adult respiratory distress syndrome/acute respiratory failure, pulmonary oedema, or respiratory complications of anaesthesia), cerebrovascular complications (subarachnoid haemorrhage, intracerebral haemorrhage, cerebral infarction, other central nervous system disorders, or central nervous system complications of anaesthesia), pulmonary embolism (pulmonary embolism or amniotic fluid embolism), and acute renal failure. The transfusion criteria of the Ministry of Health, Labour and Welfare of Japan for acute intraoperative bleeding recommend red blood cell transfusion when the haemoglobin concentration is <6.0 g/dl and fresh frozen plasma transfusion only for the treatment of bleeding tendencies caused by deficiencies of coagulation factors. 23 Based on these criteria, we considered that 'red blood cell transfusion on the day of delivery' and 'fresh frozen plasma transfusion on the day of delivery' suggested the presence of major haemorrhage and disseminated intravascular coagulation, respectively. The ICD-10 codes used to identify these life-threatening complications are listed in Appendix 1. These ICD-10 codes were extracted from 'complications that occurred after admission' in the database.
Exposure variable
The mode of anaesthesia was recorded as spinal, epidural, general anaesthesia, a combination of them, or other. We categorized spinal, epidural, and the combination of spinal and epidural anaesthesia as neuraxial anaesthesia. General anaesthesia alone was categorized as general anaesthesia. Patients who received both general and neuraxial anaesthesia were excluded. When neuraxial anaesthesia is insufficient or critical vital signs emerge under neuraxial anaesthesia, the mode of anaesthesia is usually converted to general anaesthesia. However, the database did not include information about the cause of conversion or combination of anaesthetic techniques; hence, we could not categorize these patients into either the general anaesthesia group or the neuraxial anaesthesia group. We also excluded patients with missing data on anaesthesia.
Covariates
The available covariates were maternal demographic characteristics, obstetric characteristics, comorbidities on admission, quality of anaesthetic care, and hospital characteristics ( Table 1 ). The covariates were selected based on clinical judgment and the existing literature. 24e32 Among these comorbidities, sickle cell disease and cystic fibrosis were possible risk factors for severe maternal morbidity in previous studies. 33, 34 The prevalence of these diseases was extremely low among the Japanese population, and neither was observed in this study; thus, we did not adopt them as covariates. We extracted data to classify patients according to the type of anaesthetic coverage available for surgery. This classification was based on the incentive anaesthetic management fee, which is added when the required criteria described by the Ministry of Health, Labour and Welfare of Japan are met. 35 The detailed required criteria for the anaesthetic management fee are presented in Appendix 2.
Hospital type was categorized into academic or nonacademic. Hospitals were stratified based on the annual number of Caesarean deliveries performed at each hospital. The first, second, and third tertiles were defined as low-, intermediate-, and high-volume hospitals, respectively. The numbers of Caesarean deliveries performed at each hospital during the study period were summed using the hospital identifier, and the annual numbers of Caesarean deliveries performed at each hospital were averaged along with the respective participation period. The ICD-10 codes used to identify the presence of these obstetric characteristics and comorbidities are listed in Appendix 3. These ICD-10 codes were extracted from 'comorbidities on admission' in the database.
Statistical analysis
Continuous variables are presented as mean (standard deviation) or median (10the90th percentile) where appropriate. Categorical variables are presented as number (percentage). The balance of categorical variables between the two groups was compared using the chi-square test or quantified using the absolute standardized difference where appropriate. 36 We performed a propensity score-matched analysis to reduce confounding bias and potential baseline differences between the two groups. Propensity scores were estimated using a multivariable logistic regression model, with the receipt of general anaesthesia as the dependent variable. The independent variables included the following potential confounders: age, BMI, gestational age at delivery, pregnancy-induced hypertension, previous Caesarean delivery and/or history of uterine surgery, multiple gestation, uterine leiomyoma, abnormal placentation, anaemia, diabetes mellitus, pre-existing hypertension, asthma, chronic renal disease, chronic liver disease, pulmonary hypertension, congenital heart disease, chronic ischaemic heart disease, chronic congestive heart failure, valvular disease, cardiomyopathy, systemic lupus erythematosus, thrombocytopaenia/coagulopathy, hypercoagulable state, malignancy, HIV infection, drug abuse, history of organ transplant, quality of anaesthetic care, hospital type, and hospital volume. The C-statistic was calculated to evaluate the goodness of fit. A one-to-one matched analysis using nearestneighbour matching was performed based on the maternal estimated propensity scores. A match occurred when a woman in the general anaesthesia group had an estimated propensity score within a calliper width of 0.2 standard deviation of the propensity score of a woman in the neuraxial anaesthesia group. Absolute standardized differences were computed to examine the balance in covariates between the two groups. An absolute standardized difference of >0.1 was considered to be imbalanced. 36 We performed propensity score-adjusted logistic regression analyses to evaluate the association between mode of anaesthesia and severe maternal morbidity, fitted with generalized estimating equations to adjust for patient clustering within hospitals.
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Odds ratios are presented with their 95% CIs. All reported P values were two-sided, and a P value of <0.05 was considered statistically significant. We used SPSS Statistics for Windows, version 20.0 (IBM Corp., Armonk, NY, USA) to carry out all analyses in this study.
Results
We identified 95 232 women who underwent scheduled Caesarean delivery during the study period. After exclusions (Fig. 1 (Table 1) . In total, 10 046 pairs of patients in the general and neuraxial anaesthesia groups were selected by one-to-one propensity score matching. The C-statistic for goodness of fit was 0.608 (95% CI, 0.602e0.614) in the propensity score model. After propensity score matching, maternal and hospital characteristics were well balanced between the two groups ( Table 1) . Table 2 demonstrates the hierarchical stratification of the proportions of severe maternal morbidity before propensity score matching. Table 2 suggests that there were no significant differences between the proportions of severe maternal morbidity and the presence or absence of incentive anaesthetic management fee in each group among academic and non-academic hospitals. Table 3 shows the proportions of severe maternal morbidity and life-threatening complications, as well as the odds ratios for general anaesthesia vs neuraxial anaesthesia in the propensity score-matched groups. The odds ratio of severe maternal morbidity was 2.68 (95% CI, 1.97e3.64) among women who received general anaesthesia compared with those who received neuraxial anaesthesia. With respect to life-threatening complications, women who received general anaesthesia demonstrated higher proportions of sepsis and transfusions of red blood cells and fresh frozen plasma on the day of delivery than did those who received neuraxial anaesthesia. However, the CI of odds ratio of sepsis was wide due to the small number of women experiencing sepsis in each group. No significant difference was observed in the proportions of respiratory complications, cardiovascular complications, cerebrovascular complications, shock 
Discussion
In this propensity score-matched analysis of a Japanese national database, we observed that, among women undergoing scheduled Caesarean delivery, the rate of severe maternal morbidity was significantly higher among those who underwent general anaesthesia compared with neuraxial anaesthesia. To our knowledge, there are no reports about the risk of anaesthesia on severe maternal morbidity during Caesarean delivery. However, we cannot clearly confirm with confidence the extent and strength of the relation between mode of anaesthesia and severe maternal morbidity because we could not exclude confounding by indication. Although we do not have survey data to assess how anaesthesiologists perform general anaesthesia, we provide an example of a typical approach for a general anaesthesia for Caesarean delivery in Japan, based on our institutional and anecdotal experience: a histamine-2 blocker is administered preoperatively to minimize the risk of aspiration. After about 5 minutes' preoxygenation, a rapid sequence induction with cricoid pressure is performed. Either propofol or thiopental is administered, followed by either rocuronium or succinylcholine. Opioids are not commonly administered initially. Before the birth, anaesthesia is maintained using nitrous oxide and volatile anaesthetics such as sevoflurane and desflurane. After the delivery, administration of opioids such as fentanyl and remifentanil is started. Many anaesthesiologists switch from volatile anaesthetics to continuous administration of propofol to avoid uterine atony.
Anaesthesiologists empirically select general anaesthesia rather than neuraxial anaesthesia for emergency Caesarean deliveries, women with conditions associated with major haemorrhage (such as abnormal placentation), or women with contraindications to neuraxial anaesthesia (such as severe thrombocytopaenia), which could cause confounding by indication. To attempt to control for confounders, we focused on scheduled Caesarean deliveries and we performed propensity score-matched analyses. By focusing on scheduled Caesarean delivery, we reduced the effects of confounding by indication related to emergency such as profound foetal bradycardia, ruptured uterus, and placental abruption. Further, by using propensity score-matched analyses, we controlled for the effects of confounders related to characteristics and comorbidities of patients, and confounding by indication related to haemorrhagic conditions such as placenta praevia, uterine leiomyoma, and thrombocytopaenia/coagulopathy.
We conducted logistic regression analyses fitted with generalized estimating equations in the propensity score-matched groups for life-threatening complications to elucidate the association between general anaesthesia and severe maternal morbidity during the admission for Caesarean delivery. In particular, the incidence of red blood cell transfusion on the day of delivery was significantly higher in the general anaesthesia group. The suppressive effect of anaesthetic agents on uterine contraction and platelet function is considered to be one of the possible mechanisms associated with the increased risk of major haemorrhage in patients undergoing general anaesthesia. 12, 13 The necessity of the fresh frozen plasma transfusion suggests the presence of major haemorrhage and subsequent disseminated intravascular coagulation. The higher occurrence rate of fresh frozen plasma transfusion on the day of delivery in patients Table 1 Continued Covariates Before propensity score matching (n ¼ undergoing general anaesthesia may be secondary to major postpartum haemorrhage. General anaesthesia was also associated with a higher incidence of sepsis, although the CI of odds ratio of sepsis was wide, due to the small number of incidences. The impact of general anaesthesia on the immune system is controversial, and also the influence of anaesthesia on the incidence of sepsis during Caesarean delivery is unclear. 38, 39 Complications related to airway management and ventilation have been recognized as important causes of anaesthesia-related maternal mortality; however, recent advancements in upper airway management devices have reduced the risk ratio for deaths occurring from general anaesthesia relative to those from neuraxial anaesthesia. 3, 6 In this study, we found that the incidence of respiratory complications was not significantly different between general anaesthesia and neuraxial anaesthesia. However, the incidences of respiratory complications and other residual individual life-threatening complications were too small to draw meaningful conclusions. This study has several limitations. (1) The recorded diagnoses in administrative datasets are generally less well-validated than those in planned prospective surveys. In particular, morbidly adherent placenta, which could be a major cause of confounding by indication, may not be correctly diagnosed before delivery. (2) The effects of confounding by indication could not be completely eliminated. Further, we could not entirely exclude the possibility of unmeasured confounders such as race, socioeconomic status, marital status, religious/cultural beliefs, education level, laboratory data, amount of blood loss, fetal condition, skill of surgeon, duration of surgical procedure, and time of delivery. (3) In general terms in propensity score-matched analysis, a large number of cases who could not be matched are excluded from the analysis. (4) Participation in the Diagnosis Procedure Combination database is voluntary for each hospital. In 2012, the rate of participation in the database was about 70% among highvolume hospitals, whereas it was about 10% among lowvolume hospitals; therefore, the database may not represent the average Japanese population. 19 The rate of scheduled
Caesarean deliveries under general anaesthesia in this study (11.3%) was higher than that in a previous report from New York state (5.6% in 2012). 40 This result suggests that our database may include more patients with severe complications who would be preferably treated at high-volume hospitals. (5) The numbers of individual life-threatening complications were quite low. Therefore we could not conclude whether mode of anaesthesia is associated with these rare complications. (6) The causes of conversion of the two types of anaesthesia could not be identified, thus we excluded these patients from the analyses. However, an intraoperative complication may have contributed to the conversion from neuraxial to general anaesthesia. (7) The proportion of obese women in this study was much lower than that in Western countries, and this might have influenced the results. (8) Confounding by anaesthesia provider may exist. In Japan, some obstetricians occasionally provide anaesthesia in small facilities where there is no regular anaesthesiologist. Although data were not available for the provider who primarily administered anaesthesia, we attempted to derive information about the type of anaesthesia coverage from anaesthesia billing (presence of incentive anaesthetic management fee). Although we observed no differences in rates of severe maternal morbidity according to the type of anaesthesia used in hospitals with vs without an incentive fee (Table 2) , data from the incentive fee does not specify which type of provider who delivered anaesthesia. Future studies are needed to examine whether the type and experience of the provider who delivers anaesthesia influences the rate of anaesthesia-related severe maternal morbidity. (9) The present results could have been influenced by the definition of severe maternal morbidity. Alternative Data are presented as n (proportion of severe maternal morbidity [%]). * There was no significant difference in the proportion of severe maternal morbidity (P¼0.24, chi-square test). ¶ There was no significant difference in the proportion of severe maternal morbidity (P¼0.86, chi-square test). y There was no significant difference in the proportion of severe maternal morbidity (P¼0.67, chi-square test). z There was no significant difference in the proportion of severe maternal morbidity (P¼0.41, chi-square test). definitions of severe maternal morbidity (e.g. emergency hysterectomy, intensive care unit admission, or artificial ventilation) might lead to results different from our findings. (10) This study included only scheduled Caesarean deliveries. (11) We did not consider the influence of anaesthesia on the fetus.
In conclusion, among women undergoing scheduled Caesarean delivery, the incidence of severe maternal morbidity was higher among those receiving general anaesthesia compared with those receiving neuraxial anaesthesia. General anaesthesia was mainly associated with haemorrhagic complications. However, we should be cautious with interpretation of these findings because the effects of confounding by indication could not be completely eliminated. Until further studies are performed, the decision regarding the most appropriate anaesthetic technique for Caesarean delivery should be individualized.
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